Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patients

International Journal of Antimicrobial Agents

Volumn 40, Issue 2, 2012, Pages 123-126

  Ram, Ron ^a,b   Farbman, Laura ^a   Leibovici, Leonard ^a,b   Raanani, Pia ^a,b   Yeshurun, Moshe ^a,b   Vidal, Liat ^a,b   Gafter Gvili, Anat ^a,b   Peck, Anat ^a   Shpilberg, Ofer ^a,b   Paul, Mical ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Appropriate empirical antibiotic treatment; Bacteraemia; Breakthrough infections; Haematology; Haematopoietic stem cell transplantation

Indexed keywords

CARBAPENEM; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; METICILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; DISEASE COURSE; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEVER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMATOLOGIC MALIGNANCY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BACTERIAL INFECTIONS; CEFTAZIDIME; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FEVER; GRAM-POSITIVE BACTERIA; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMANS; ISRAEL; MIDDLE AGED; ODDS RATIO; PENICILLANIC ACID; PIPERACILLIN; PROSPECTIVE STUDIES; THIENAMYCINS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864290726     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.05.001     Document Type: Article

References (15)

1. M. Paul, V. Shani, E. Muchtar, G. Kariv, E. Robenshtok, and L. Leibovici Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis Antimicrob Agents Chemother 54 2010 4851 4863
2. M.Y. Lin, R.A. Weinstein, and B. Hota Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia Antimicrob Agents Chemother 52 2008 3188 3194
3. R. Ramphal Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens Clin Infect Dis 39 Suppl. 1 2004 S25 S31
4. H. Wisplinghoff, H. Seifert, R.P. Wenzel, and M.B. Edmond Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States Clin Infect Dis 36 2003 1103 1110
5. C. Cattaneo, G. Quaresmini, S. Casari, M.A. Capucci, M. Micheletti, and E. Borlenghi Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution J Antimicrob Chemother 61 2008 721 728
6. A.L. Oliveira, M. de Souza, V.M. Carvalho-Dias, M.A. Ruiz, L. Silla, and P.Y. Tanaka Epidemiology of bacteremia and factors associated with multi-drug-resistant Gram-negative bacteremia in hematopoietic stem cell transplant recipients Bone Marrow Transplant 39 2007 775 781
7. R. Ram, A. Gafter-Gvili, P. Raanani, M. Yeshurun, O. Shpilberg, and J. Dreyer Surveillance of infectious complications in hemato-oncological patients Isr Med Assoc J 11 2009 133 137
8. From the Immunocompromised Host Society The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel J Infect Dis 161 1990 397 401
9. B. De Pauw, T.J. Walsh, J.P. Donnelly, D.A. Stevens, J.E. Edwards, and T. Calandra Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Clin Infect Dis 46 2008 1813 1821
10. T.C. Horan, M. Andrus, and M.A. Dudeck CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting Am J Infect Control 36 2008 309 332
11. A.G. Freifeld, E.J. Bow, K.A. Sepkowitz, M.J. Boeckh, J.I. Ito, and C.A. Mullen Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America Clin Infect Dis 52 2011 e56 e93
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. Document M100-S15. Wayne, PA: CLSI; 2005.
13. C.S. Tam, M. O'Reilly, D. Andresen, S. Lingaratnam, A. Kelly, and K. Burbury Use of empiric antimicrobial therapy in neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee Intern Med J 41 2011 90 101
14. H. Link, A. Böhme, O.A. Cornely, K. Höffken, O. Kellner, and W.V. Kern Antimicrobial therapy of unexplained fever in neutropenic patients - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society) Ann Hematol 82 Suppl. 2 2003 S105 S117
15. F. Meunier, and C. Lukan The First European Conference on Infections in Leukaemia - ECIL1: a current perspective Eur J Cancer 44 2008 2112 2117